The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis
Open accessAbstract
The primary aim of this systematic review and meta-analysis was to assess the proportion of patients with Treatment Resistant Schizophrenia (TRS) that respond to ECT augmentation of clozapine (C+ECT). We searched major electronic databases from 1980 to July 2015. We conducted a random effects meta-analysis reporting the proportion of responders to C+ECT in RCTs and open-label trials. Five clinical trials met our eligibility criteria, allowing us to pool data from 71 people with TRS who underwent C+ ECT across 4 open label trials (n=32) and 1 RCT (n=39). The overall pooled proportion of response to C+ECT was 54%, (95% CI: 21.8-83.6%) with some heterogeneity evident (I(2)=69%). With data from retrospective chart reviews, case series and case reports, 192 people treated with C+ECT were included. All studies together demonstrated an overall response to C+ECT of 66% (95% CI: 57.5-74.3%) (83 out of 126 patients responded to C+ECT). The mean number of ECT treatments used to augment clozapine was 11.3. 32% of cases (20 out of 62 patients) with follow up data (range of follow up: 3-468weeks) relapsed following cessation of ECT. Adverse events were reported in 14% of identified cases (24 out of 166 patients). There is a paucity of controlled studies in the literature, with only one single blinded randomised controlled study located, and the predominance of open label trials used in the meta-analysis is a limitation. The data suggests that ECT may be an effective and safe clozapine augmentation strategy in TRS. A higher number of ECT treatments may be required than is standard for other clinical indications. Further research is needed before ECT can be included in standard TRS treatment algorithms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
Kennedy, J. L., Altar, C. A., Taylor, D. L., Degtiar, I., & Hornberger, J. C. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836508e6 · Cited by 392
Information, consent and perceived coercion: patients' perspectives on electroconvulsive therapy
Rose, D. S., Wykes, T. H., Bindman, J. P., & Fleischmann, P. S. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.1.54 · Cited by 102
Cited by
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 304
Weiss, A., Hussain, S., Ng, B., Sarma, S., Tiller, J., Waite, S., & Loo, C. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419839139 · Cited by 167
Key updates in the clinical application of electroconvulsive therapy
Weiner, R. D., & Reti, I. M. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1309362 · Cited by 166
ECT in schizophrenia:a review of the evidence
Grover, S., Sahoo, S., Rabha, A., & Koirala, R. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.32 · Cited by 122
Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study
Tang, V. M., Blumberger, D. M., McClintock, S. M., Kaster, T. S., Rajji, T. K., Downar, J., Fitzgerald, P. B., & Daskalakis, Z. J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00310 · Cited by 29
Metadata
- Authors
- Lally, J., Tully, J., Robertson, D., Stubbs, B., Gaughran, F., & MacCabe, J. H.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 171
- Issue
- 1-3
- Pages
- 215-224
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2283214644
- Cited by
- 172
- References
- 3
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.